Spain · AEMPS CIMA
DOXAZOSINA NEO CINFA 4 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75009
- Form
- COMPRIMIDO DE LIBERACIÓN PROLONGADA
- Composition / generic term
- doxazosina
- Source strength
- 4.85 mg (correspondiente a 4.00 mg de doxazosina)
- Authorisation holder
- Laboratorios Cinfa S.A.
- Marketed in source snapshot
- Yes
Source-listed ingredients
- DOXAZOSINA MESILATO — 4,85 mg
These values do not establish equivalence or a dose recommendation.
Packages
- DOXAZOSINA NEO CINFA 4 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG , 28 comprimidos
Source and coverage
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →